Published in Obesity and Diabetes Week, October 11th, 2004
This concludes the company's C financing round, which now totals $14.8 million.
Glucon's device reads glucose (sugar) levels directly from blood vessels using the photo-acoustic effect and its proprietary imaging technology. It is estimated that by the close of 2010, 24 million in the U.S. and 220 million worldwide will suffer from diabetes. Currently, 16 million Americans are diabetic.
Ascend Technology Ventures manages $100M for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.